TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Net Income towards Common Stockholders (2020 - 2023)

Updated

TFA Therapeutics' Net Income towards Common Stockholders came in at -$154,822 for FY2025, compared with -$226,258 in FY2024.

Analysis

TFA Therapeutics (RAJAF) Net Income towards Common Stockholders (2020 - 2023) Analysis & Trends

Going back to FY2020, TFA Therapeutics' Net Income towards Common Stockholders data covers 6 years.

  • The five-year range for annual Net Income towards Common Stockholders is -$720,093 (FY2022) to $751,609 (FY2023).
  • Per Business Quant, earlier years put Net Income towards Common Stockholders at -$226,258 in FY2024, $751,609 in FY2023, -$720,093 in FY2022 and -$491,006 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn 3.04 Bn
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn 693.00 Mn
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn -116.00 Mn
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn 456.00 Mn
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn 345.00 Mn
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn 202.80 Mn
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn 163.00 Mn
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn 66.60 Mn
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn 89.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 901,171.00
Dec 31, 2022 -77,046.00
Dec 31, 2020 -13,476.00
API Access

TFA Therapeutics Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RAJAF&period=max&api_key=YOUR_API_KEY